Back to results
US 2026/0308221 A1Published application
Targeted engineered interferon and uses thereof
AssigneeOrionis Biosciences BV
InventorsNikolai KLEY, Lennart ZABEAU, Jan TAVERNIER
Life of this patent
Estimating the term…
Abstract
The present invention relates, in part, to chimeric proteins comprising consensus interferon, or a variant thereof, and their use as therapeutic agents.
Claims19
-44. (canceled)
A chimeric protein comprising:
- (a) a variant consensus interferon comprising the amino acid sequence of SEQ ID NO:
- 2 and having one or more mutations at an amino acid position selected from 146 and 150 with reference to SEQ ID NO:
- 2;
- and
- (b) one or more targeting moieties, said targeting moieties comprising recognition domains comprising single-domain antibodies which specifically bind to target antigens or receptors;
- and
- wherein the variant consensus interferon and the one or more targeting moieties are optionally connected with one or more linkers.
4 more elements
Dependencies are inferred from the claim text.